4BDG | Transferase | date | Oct 05, 2012 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Fragment-Based Screening Identifies A New Area For Inhibitor To Checkpoint Kinase 2 (Chk2) | ||||||||||||||
authors | M.C.Silva-Santisteban, I.M.Westwood, K.Boxall, N.Brown, S.Peacoc C.Mcandrew, E.Barrie, M.Richards, A.Mirza, A.W.Oliver, R.Burke, S K.Jones, G.W.Aherne, J.Blagg, I.Collins, M.D.Garrett, R.L.M.Van | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Serinethreonine-Protein Kinase Chk2 Chain: A Fragment: Kinase Domain, Residues 210-531 Synonym: Chk2 Checkpoint Homolog, Cds1 Homolog, Hucds1, Hcd Checkpoint Kinase 2; Ec: 2.7.11.1 Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Expression_system: Escherichia Coli Expression_system_taxid: 469008 Expression_system_strain: Bl21(De3) Expression_system_variant: Rosetta2 Plyss Expression_system_vector_type: Plasmid Expression_system_plasmid: Pthree-E | ||||||||||||||
symmetry | Space Group: P 32 2 1 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.84 Å | ||||||||||||
ligand | CL, EDO, NO3, P3J | enzyme | Transferase E.C.2.7.11.1 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Fragment-Based Screening Maps Inhibitor Interactions in the ATP-Binding Site of Checkpoint Kinase 2., Silva-Santisteban MC, Westwood IM, Boxall K, Brown N, Peacock S, McAndrew C, Barrie E, Richards M, Mirza A, Oliver AW, Burke R, Hoelder S, Jones K, Aherne GW, Blagg J, Collins I, Garrett MD, van Montfort RL, PLoS One. 2013 Jun 12;8(6):e65689. doi: 10.1371/journal.pone.0065689. Print 2013. PMID:23776527 |
Data retrieval |
View 4BDG in 3D |
Visual 3D analysis of 4BDG |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4BDG |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |